Determinants of biological drug survival in rheumatoid arthritis: evidence from a Hungarian rheumatology center over 8 years of retrospective data

OBJECTIVE: To compare drug survival of biological therapies in patients with rheumatoid arthritis (RA), and analyze the determinants of discontinuation probabilities and switches to other biological therapies. MATERIALS AND METHODS: Consecutive RA patients initiating first biological treatment in on...

Descripción completa

Detalles Bibliográficos
Autores principales: Brodszky, Valentin, Bíró, Anikó, Szekanecz, Zoltán, Soós, Boglárka, Baji, Petra, Rencz, Fanni, Tóthfalusi, László, Gulácsi, László, Péntek, Márta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5317255/
https://www.ncbi.nlm.nih.gov/pubmed/28243133
http://dx.doi.org/10.2147/CEOR.S124381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5317255/
https://www.ncbi.nlm.nih.gov/pubmed/28243133
http://dx.doi.org/10.2147/CEOR.S124381

Ejemplares similares